tiprankstipranks

Steve E. Krognes Insider Profile

4 Followers
Steve E. Krognes, Director at Guardant Health, holds 14.58K shares in Guardant Health (Ticker: GH), holds ― shares in Pliant Therapeutics (Ticker: PLRX), holds 820.00K shares in Denali Therapeutics (Ticker: DNLI).
tipranks
Steve E. Krognes

Steve E. Krognes
Guardant Health (GH)
Director

Ranked #26,851 out of 108,921 Corporate Insiders

Profitable Transactions

71%
12 out of 17 Profitable Transactions

Average Return

+3.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$21M
88.59%
11.41%
0.00%
0.00%
A breakdown of Steve E. Krognes's holdings

Insider Roles

Denali Therapeutics
(DNLI)
Director
Guardant Health
(GH)
Director
Pliant Therapeutics
(PLRX)
Director
Corvus Pharmaceuticals
(CRVS)
Director
Roles that Steve E. Krognes holds in companies

Most Profitable Insider Trade

Stock:
Denali Therapeutics
(DNLI)
Rating:Informative Sell
Date:Feb 16, 2021 - Feb 16, 2022
Return:+44.30%
The most profitable trade made by Steve E. Krognes

Steve E. Krognes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Guardant Health
Jul 02, 2026
Director
Uninformative Buy
23.25K
$2.35M
Pliant Therapeutics
Director
Denali Therapeutics
Jun 05, 2026
Director
Uninformative Buy
$18.27M
Corvus Pharmaceuticals
Director
GRTSQ
Gritstone bio
List of latest transactions for each holding click on a transaction to see Steve E. Krognes's performance on stock

Steve E. Krognes insider profile FAQ

What is the percentage of profitable transactions made by Steve E. Krognes?
The percentage of profitable transactions made by Steve E. Krognes is 71%.
    What is the average return per transaction made by Steve E. Krognes?
    The average return per transaction made by Steve E. Krognes is 3.20%.
      What stocks does Steve E. Krognes hold?
      Steve E. Krognes holds: GH, PLRX, DNLI, CRVS, GRTSQ stocks.
        What was Steve E. Krognes’s latest transaction?
        Steve E. Krognes latest transaction was an Uninformative Buy of $23.25K.
          What was Steve E. Krognes's most profitable transaction?
          Steve E. Krognes’s most profitable transaction was an Informative Sell of DNLI stock on February 16, 2021. The return on the trade was 44.30%.
            What is Steve E. Krognes's role in Guardant Health?
            Steve E. Krognes's role in Guardant Health is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.